Corticosteroids in sepsis: A new concept for an old drug

Israel Medical Association Journal

Volumn 5, Issue 1, 2003, Pages 51-55

  Klaitman, Vered ^a   Almog, Yaniv ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Adrenal insufficiency; Anti inflammatory; Corticosteroids; Cytokines; Septic shock

Indexed keywords

DISEASES; HEALTH; PATIENT TREATMENT;

ANTI-INFLAMMATORY THERAPY;

DRUG PRODUCTS;

ANTIINFLAMMATORY AGENT; BETAMETHASONE; CATECHOLAMINE; CORTICOSTEROID ANTAGONIST; CORTICOSTEROID DERIVATIVE; CORTICOTROPIN; CYTOKINE; DEXAMETHASONE; FLUDROCORTISONE; GLUCOCORTICOID; HYDROCORTISONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHYLPREDNISOLONE; MIFEPRISTONE; MINERALOCORTICOID; STEROID; VASOPRESSIN;

ADRENAL INSUFFICIENCY; ANTIINFLAMMATORY ACTIVITY; BACTEREMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; DRUG USE; DRUG WITHDRAWAL; HUMAN; IMMUNE RESPONSE; INFECTION; INFLAMMATION; LONG TERM CARE; LOW DRUG DOSE; NONHUMAN; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEPSIS; SEPTIC SHOCK; SHORT COURSE THERAPY; TREATMENT FAILURE;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; CATECHOLAMINES; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NF-KAPPA B; PITUITARY-ADRENAL SYSTEM; SEPSIS; SHOCK, SEPTIC;

EID: 0037275649     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med 1999;340:207-14.
2. Brun-Buisson C, Doyon F, Carlet J. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. JAMA 1995;274:968-74
3. Balk AR. Severe sepsis and septic shock. Crit Care Clin 2000;16:179-92.
4. Chrousos GP. The hypothalamic-pituitary adrenal axis and immune mediated inflammation. N Engl J Med 1995;332:1351-62.
5. Cronin L, Cook DJ, Carlet J, et al. Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of literature. Crit Care Med 1995;23:1430-9.
6. Carlet J. Steroid therapy during septic shock: A second birth? Adv Sepsis 2001;3:93-6.
7. Briegel J, Jochum M, Gippner-Steppert C, Thiel M. Immunomodulation in septic shock: Hydrocortisone differentially regulates cytokine responses. J Am Soc Nephrol 2001;12:S70-4.
8. Abraham E. Shy immunomodulatory therapies have not worked in sepsis? Intensive Care Med 1999;25:556-66.
9. Chin R, Eagerton DC, Salem M. Corticosteroids. In: Chernow B, ed. The Pharmacologic Approach to the Critically Ill Patient. 3rd edn. Philadelphia: Williams & Wilkins, 1994; Chap. 43: 715-37.
10. Flower RJ. The mediators of steroid action. Nature 1986;320:20.
11. Hahn EO, Houser HB, Rammelkamp CH. Effect of cortisone on acute streptococcal infections and post streptococcal complications. J Clin Invest 1951;30:274-81.
12. Lefering R, Neugebauer EAM. Steroid controversy in sepsis and septic shock: A meta-analysis. Crit Care Med 1995;23:1294-303.
13. Hoffman SL, Punjabi NH, Kumala S, et al. Reduction of mortality in chloramphenicol treated severe typhoid fever by high dose dexamethasone. N Engl J Med 1984;310:82-8.
14. Gagnon S, Boota AM, Fischl MA, Baier H, Kirksey OW, La Voie L. Corticosteroids as adjunctive therapy for severe pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: A double blind placebo controlled trial. N Engl J Med 1990;323:1440-50.
15. Odio CM, Faingezicht I, Paris M, et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med 1991;324:1525-31.
16. Chawla K, Kupfer Y, Goldman I, Tessler S. Hydrocortisone reverses refractory septic shock. Crit Care Med 1999;27:33A.
17. Oberbeck R, Dahlweid M, Koch R, et al. Dehydroepiandrosterone decreases mortality rate and improves cellular immune function during polymicrobial sepsis. Crit Care Med 2001;29:380-4.
18. Briegel J, Forst H, Haller M, et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study. Crit Care Med 1999;27:723-32.
19. Bollaert PE, Charpentier C, Levy B, et al. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998;26:645-50.
20. Annane D, Sébille V, Troché G, Raphaël JC, Gajdos P, Bellissant E. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000;283:1038-45.
21. Annane D. Effects of combination of hydrocortisone and fluorocortisone on mortality in septic shock. Crit Care Med 2000;28:A46 [Abstract 63].
22. Annane D. Corticosteroids for septic shock. Crit Care Med 2001;29:S117-20.
23. Almog Y, Jackson EV, Chernow B. Adrenal insufficiency and corticosteroids: Applications in critical illness. In: Parrilo J, ed. Current Therapy in Critical Care Medicine. 3rd edn. St. Louis: Mosby, 1997:82-8.
24. Ihle BU. Adrenocortical response and cortisone replacement in systemic inflammatory response syndrome. Anaesth Intensive Care 2001;29:155-62.
25. Rydvall A, Brandstrom AK, Banga R, Asplund K, Backlund U, Stegmayr BG. Plasma cortisol is often decreased in patients treated in an intensive care unit. Intensive Care Med 2000;26(5):545-51.
26. Soni A, Pepper GM, Wyrwinski PM, et al. Adrenal insufficiency occurring during septic shock: Incidence, outcome and relationship to peripheral cytokine levels. Am J Med 1995;98:266-71.
27. Koo DJ, Jackman D, Chaudry IH, Wang P. Adrenal insufficiency during the late stage of polymicrobial sepsis. Crit Care Med 2001;29:618-22.
28. Schroeder S, Wichers M, Klingmuller D, et al. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: Altered response to corticotropin-releasing hormone. Crit Care Med 2001;29:310-16.
29. Oelkers W. Adrenal insufficiency. N Engl J Med 1996;335:1206-13.
30. Moran JL, Chapman MJ, O'Fathartaigh MS. Hypocortisolemia and adrenocortical responsiveness at onset of septic shock. Intensive Care Med 1994;20:489-95.
31. Chrousos GP. The hypothalamic-pituitary adrenal axis and immune mediated inflammation. N Engl J Med 1995;332:1351-62.
32. Oppert M, Reinicke A, Graf KJ, Barckow, D, Frei U, Eckardt KU. Plasma cortisol levels before and during "low-dose" hydrocortisone therapy and their relationship to hemodynamic improvement in patients with septic shock. Intensive Care Med 2000;26:1747-55.
33. Briegel J. Hydrocortisone and the reduction of vasopressors in septic shock: Therapy or only chart cosmetics? [Review]. Intensive Care Med 200026(12):1723-6.
34. Bellissant E, Annane D. Effect of hydrocortisone on phenylephrine - Mean arterial pressure dose-response relationship in septic shock. Clin Pharmacol Ther 2000;68(3):293-303.
35. Grunfeld JP, Eloy L. Glucocorticoids modulate vascular reactivity in the rat. Hypertension 1987;10:608-18.
36. Yard AC, Kadowitz PJ. Studies of the mechanisms of hydrocortisone potentiation of vasoconstrictor responses to epinephrine in the anesthetized animal. Eur J Pharmacol 1972;20:1-9.
37. Spijkstra J, Girbes AR. The continuing story of corticosteroids in the treatment of septic shock. Intensive Care Med 2000;26(5):496-500.
38. Van Leeuwen HJ, Van Der Bruggen T, Van Asbeck BS, Boereboom FT. Effect of corticosteroids on nuclear factor-kappaB activation and hemodynamics in late septic shock. Crit Care Med 2001;29:1074-7.
39. Penner CG, Gang G, Wray C, Fisher JE, Hasselgren PO. The transcription factors NF-kappab and AP-1 are differentially regulated in skeletal muscle during sepsis. Biochem Biophys Res Commun 2001;281:1331-6.
40. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr. Role of transcriptional activation of Iκ B in mediation of immunosuppression by glucocorticoids. Science 1995;270:283-6.